Chemence Medical Receives FDA Clearance for new Exofin® Precision

Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell the Exofin® Precision Pen as a new medical device for wound closure. The Exofin Precision Pen will enable medical providers greater versatility and exactness in closing wounds while also improving ease of use in applying topical skin adhesive.

View full article here: https://www.businesswire.com/news/home/20220131005076/en/

Shop Precision Pen: https://herzogsurgical.com/product/exofin-precision-pen/